Abstract:Abstract Background/Aims For ideal pregnancy outcomes, patients with inflammatory rheumatic disease require targeted disease control with pregnancy compatible medications. A proactive approach is required given that people often won’t disclose plans for a pregnancy with healthcare professionals unless directly asked, and 45% of UK pregnancies are unplanned. The BSR 2022 guidelines on prescribing drugs in pregnancy and breastfeeding makes various recommendations on pre-pregnancy counselling for people with rheumatic disease with referral to specialists with relevant expertise as appropriate. Therefore, we used the linked BSR audit tool to evaluate documentation of pre-pregnancy counselling in rheumatology clinics lacking obstetric input at our hospital. Methods Inclusion criteria were all females, aged 15-45 years, attending a doctor-led Rheumatology clinic without obstetric input between 24/4/23 - 30/4/23 at University College London Hospital. Exclusion criteria were infertility and those seen as one-off clinic appointments and not commenced on medications. Clinic notes from all Rheumatology reviews over the preceding one year were assessed using the audit tool in the 2022 BSR pregnancy guidelines. People currently pregnant were audited for the year prior to the date of conception of their pregnancy. Results Among 50 clinics reviewed, 42 female subjects were eligible across 19 clinics, 64% of whom were aged 36-45 years and 36% were aged 21-35 years. Six subjects were pregnant. Diagnoses included: 24% systemic lupus erythematosus; 19.5% rheumatoid arthritis; 17% seronegative axial spondyloarthropathy; and the remaining 39% consisted of fibromyalgia, hypermobility, and other inflammatory arthritidies. 70% of people were screened for antibodies that could adversely impact pregnancy (i.e. anti-Ro or anti-phospholipid). Only 26% of subjects had documentation of being asked if they wished to conceive. In subjects who did not express a wish to conceive, only 21% were asked if they were using contraception. A total of 17% of the 42 subjects were referred to a specialist Obstetric-Rheumatology clinic for pre-pregnancy counselling during the study period. Of 35 subjects taking medications, only 22.8% had documentation of appropriate pre-pregnancy drug counselling within the last year. Of patients without documented pre-pregnancy advice, 46% were taking medications considered unsafe in pregnancy. Furthermore, no patients were signposted to sources of further information on drug therapy and/or rheumatic disease in pregnancy. Conclusion This audit highlights a lack of regular documented discussions around family planning and medication counselling in female subjects of childbearing age attending rheumatology clinics lacking obstetric input. Regular discussions are important for those who do and don’t wish to conceive, to appropriately counsel regarding pre-pregnancy measures or contraception. This audit using the BSR audit tool will be used as the baseline for a quality improvement project to support colleagues in providing regular, accurate reproductive health advice, supported by trusted online resources and referral to a specialist obstetric-rheumatology service as required. Disclosure A. Shirazi: None. B. Goulden: Grants/research support; Undertaking a PhD supported by Versus Arthritis (ref. 22975). I. Giles: Grants/research support; IG has received an unrestricted research grant, travel and speaker fees from UCB Pharma.

Preconception counselling in women of reproductive age attending cardiology clinics in Scotland

Pre-eclampsia and future cardiovascular disease risk: Assessing British clinicians' knowledge and practice

Women's knowledge, attitudes and views of preconception health and intervention delivery methods: a cross-sectional survey

Pregnancy and the Postpartum Period as an Opportunity for Cardiovascular Risk Identification and Management

Abstract MP74: Trends in Cardiovascular Health Counseling Among Postpartum Individuals in the United States From 2016-2020: The Pregnancy Risk Assessment Monitoring System

General practice preconception care invitations: a qualitative study of women's acceptability and preferences

Preconception health risk factors documented in general practice electronic medical records

Barriers in the Uptake and Delivery of Preconception Care: Exploring the Views of Care Providers

Best practice recommendations for medically assisted reproduction in patients with known cardiovascular disease or at high risk of cardiovascular disease

Developing consensus on priorities for preconception care in the general practice setting in the UK: study protocol

Predictors of Preconception Care Reception in a Sample of Iranian Pregnant Women Referred to Qazvin Health Centers

Barriers and facilitators of cardiovascular disease prevention services for women with prior gestational diabetes or hypertensive disorders of pregnancy in low-income, middle-income and high-income settings: a scoping review protocol

Women's views on content and delivery methods for interventions to improve preconception health: a qualitative exploration

Preliminary data on short-term outcomes within the cardio-obstetrics registry

Impact of preeclampsia on cardiovascular events: An analysis of the Generation Scotland: Scottish family health study

Hypertensive disorders of pregnancy and long-term maternal cardiovascular risk: Bridging epidemiological knowledge into personalized postpartum care and follow-up

P004 Empowering the reproductive choices of patients with rheumatic disease: using the BSR 2022 pregnancy guidelines audit tool to evaluate pre-conception medication advice

Health professionals beliefs and attitudes towards preconception care: A systematic review

Evaluating How Beliefs Among Pediatric Cardiology Providers May Affect Fetal Cardiac Counseling—A National Perspective

Critical congenital heart disease: contemporary prenatal screening performance and outcomes in a multi-centre perinatology service

Organisation of care for pregnancy in patients with congenital heart disease